Cumberland Pharmaceuticals

Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded prescription products designed to improve quality of care and address unmet medical needs.
With a focus on underserved niche markets, including hospital acute care and gastroenterology, we deliver products that serve patients in the U.S. market. Cumberland also makes its products available to patients internationally through select strategic partnerships.
We own the worldwide rights to all our brands. While Cumberland’s commercial capabilities are focused on the U.S. market, our business development team is actively pursuing opportunities to make our brands available to patients in markets around the globe.
Our primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. We also strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients.

Nashville, US
Size (employees)
82 (est)+6%
Cumberland Pharmaceuticals was founded in 1999 and is headquartered in Nashville, US

Cumberland Pharmaceuticals Office Locations

Cumberland Pharmaceuticals has office in Nashville
Nashville, US

Cumberland Pharmaceuticals Metrics

Cumberland Pharmaceuticals Summary

Market capitalization

$98.4 m

Closing share price

Cumberland Pharmaceuticals's current market capitalization is $98.4 m.

Cumberland Pharmaceuticals Financials

Cumberland Pharmaceuticals's revenue is $32 m in FY, 2013 which is a 5237.9% increase from the previous period.
FY, 2013FY, 2014FY, 2015Y, 2016


$32 m$600 k$900 k$33 m

Revenue growth, %


Net Income

($2.2 m)$2.4 m$671.1 k

Cumberland Pharmaceuticals Market Value History

Cumberland Pharmaceuticals Company Life

You may also be interested in